Depending on a patient’s health history, symptoms, treatment goals, medications, and laboratory findings, certain peptide-based medications may be considered as part of an individualized treatment plan.
Areas evaluated may include:
Hormone and metabolic health
Body composition and wellness goals
Sleep and restorative health
Sexual health and desire-related concerns
Treatment options may include medications such as sermorelin or bremelanotide when medically appropriate. The selection of any medication is based on an individualized medical evaluation, its intended clinical use, potential risks and benefits, contraindications, and applicable regulatory requirements.
Some medications may be prescribed for uses that differ from their FDA-approved labeling when a licensed healthcare provider determines that such use is medically appropriate. No specific treatment or result is guaranteed.
When compounded medications are prescribed, they are prepared by licensed compounding pharmacies. Compounded medications are not FDA-approved, and the FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Final treatment decisions are made by a licensed healthcare provider following an appropriate medical evaluation.
Peptides are short chains of amino acids involved in cellular signaling and many normal physiologic processes in the body. Certain prescription medications are peptide-based and may be considered as part of an individualized treatment plan when medically appropriate.
At Vybrant Health and Wellness, treatment is individualized based on your symptoms, health history, treatment goals, current medications, and, when appropriate, laboratory findings. A licensed medical provider evaluates whether a particular treatment option is appropriate before any medication is prescribed.
Our approach includes:
Peptide-based therapies and other prescription treatments are not appropriate for everyone. Potential side effects, contraindications, medication interactions, medical history, and alternative treatment options are considered before prescribing.
When clinically appropriate and legally permissible, treatment may include compounded medications prepared by appropriately licensed compounding pharmacies. Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
No specific medication or treatment result is guaranteed. Final treatment decisions are made by a licensed medical provider following an individualized medical evaluation.
Sermorelin is a synthetic peptide modeled after growth hormone–releasing hormone (GHRH), a naturally occurring hormone involved in signaling the pituitary gland to release growth hormone. Rather than supplying growth hormone directly, sermorelin acts on the body’s normal growth hormone signaling pathway.
Sermorelin therapy may be considered in a medically supervised setting following an appropriate clinical evaluation. Whether treatment is appropriate depends on factors such as medical history, symptoms, current medications, laboratory findings, and individual treatment goals.
Treatment is not appropriate for everyone. Potential side effects may include injection-site reactions, headache, flushing, dizziness, or nausea. Patients should discuss their complete medical history and potential risks with a licensed healthcare provider before beginning treatment.
At Vybrant Health and Wellness, sermorelin is considered only after an individualized clinical assessment. Patients receiving therapy are monitored through follow-up evaluations and laboratory testing when clinically appropriate.
When compounded sermorelin is prescribed, it is prepared by a licensed compounding pharmacy. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Treatment requires a prescription and should be used only under the supervision of a qualified healthcare provider.
Sermorelin is a peptide that stimulates the pituitary gland to release growth hormone through the body’s natural signaling pathways. This may support physiologic growth hormone secretion and can influence IGF-1 levels. Treatment should be individualized and monitored by a qualified healthcare provider based on clinical evaluation and appropriate laboratory testing.
When prescribed by a licensed healthcare provider following an appropriate medical evaluation, sermorelin is intended to stimulate the body’s natural release of growth hormone. Depending on the individual’s clinical needs and response to therapy, treatment may support:
Individual responses to treatment vary, and specific outcomes cannot be guaranteed. Sermorelin therapy should be prescribed and monitored by a qualified healthcare professional.
At Vybrant Health and Wellness, we partner with state-licensed and FDA-registered compounding pharmacies that prepare medications based on individualized prescriptions and clinical needs. These pharmacies operate in accordance with applicable state and federal regulations governing compounding practices.
Our partner pharmacies perform third-party testing through FDA and DEA-registered laboratories to support quality assurance, including verification of potency and sterility for compounded preparations.
We take a careful and structured approach when selecting pharmacy partners to ensure alignment with established standards for safety, quality, and regulatory compliance. All medications are prescribed following a comprehensive medical evaluation and are tailored to each patient’s individual treatment plan.
1 Month Supply
Injection Kit
Expedited Delivery
Prescription management and dosing guidance
Ongoing clinical monitoring and follow-up
NOTE: Treatment protocols are individualized based on clinical evaluation and patient response. In certain cases, providers may recommend cyclical use (e.g., periods of therapy followed by time off), depending on therapeutic goals and ongoing assessment
